Michael A. Weber
#144,619
Most Influential Person Now
Michael A. Weber's AcademicInfluence.com Rankings
Michael A. Weberphilosophy Degrees
Philosophy
#7717
World Rank
#10968
Historical Rank
Logic
#4756
World Rank
#6083
Historical Rank
Download Badge
Philosophy
Why Is Michael A. Weber Influential?
(Suggest an Edit or Addition)Michael A. Weber's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. (1997) (2197)
- BP as a determinant of cardiac left ventricular muscle mass. (1983) (235)
- Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. (1977) (232)
- Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS). (1988) (221)
- Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. (1976) (177)
- Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. (1994) (160)
- The importance of pulsatile components of hypertension in predicting carotid stenosis in older adults (1997) (140)
- Circadian blood pressure patterns in ambulatory hypertensive patients: effects of age. (1982) (140)
- Lead-induced hypertension: possible role of endothelial factors. (1993) (133)
- Diagnosis of mild hypertension by ambulatory blood pressure monitoring. (1994) (128)
- The circadian blood pressure pattern in ambulatory normal subjects. (1984) (126)
- Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. (2001) (123)
- β-Blockers and Plasma Renin Activity in Hypertension (1974) (122)
- Angiotensin II receptor inhibition. A new therapeutic principle. (1996) (120)
- Implications of a health lifestyle and medication analysis for improving hypertension control. (2000) (116)
- Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension. (1998) (114)
- Blood pressure effects of the angiotensin II receptor blocker, losartan. (1995) (109)
- Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity. (1976) (108)
- Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. (2007) (106)
- Validation of portable noninvasive blood pressure monitoring devices: comparisons with intra-arterial and sphygmomanometer measurements. (1988) (105)
- Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. (1998) (97)
- Divergent blood pressure responses during short‐term sodium restriction in hypertension (1980) (97)
- Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. (1974) (95)
- Automated ambulatory blood pressure monitoring: a study in age-matched normotensive and hypertensive men. (1985) (92)
- Common femoral artery ligation and local debridement: a safe treatment for infected femoral artery pseudoaneurysms. (2001) (92)
- Characterization of antihypertensive therapy by whole-day blood pressure monitoring. (1988) (92)
- Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. (1998) (89)
- Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension. (1978) (85)
- Doppler Echocardiographic Assessment of Left Ventricular Systolic and Diastolic Function in Mild Hypertension (1987) (85)
- Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. (1995) (83)
- Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report. (1992) (82)
- Discontinuation Syndrome Following Cessation of Treatment with Clonidine and Other Antihypertensive Agents (1980) (81)
- Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. (1993) (80)
- The role of post-mortem investigations in determining the cause of sudden unexpected death in infancy (2008) (73)
- Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series (2008) (73)
- In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Kra (2005) (73)
- Prazosin: Preliminary Report and Comparative Studies with Other Antihypertensive Agents (1974) (72)
- Arterial compliance abnormalities in isolated systolic hypertension. (2001) (72)
- Disparate patterns of aldosterone response during diuretic treatment of hypertension. (1977) (68)
- Cardiac muscle mass during vasodilation therapy of hypertension (1983) (68)
- Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscle. (1982) (67)
- Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements. (1990) (66)
- Monotherapy of essential hypertension with a converting-enzyme inhibitor. (1983) (64)
- Dependency of arterial compliance on circulating neuroendocrine and metabolic factors in normal subjects. (1992) (64)
- Measuring hypertensive cardiovascular risk: the vascular overload concept. (1994) (64)
- Low-dose combination therapy: an important first-line treatment in the management of hypertension. (2001) (62)
- Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension. (1983) (62)
- Emerging treatments for hypertension: potential role for vasopeptidase inhibition. (1999) (61)
- A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. (2001) (60)
- Left ventricular diastolic filling alterations in normotensive young adults with a family history of systemic hypertension. (1991) (59)
- Renin and aldosterone suppression in the antihypertensive action of clonidine. (1976) (58)
- Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators. (2000) (57)
- Renal effects of beta-adrenoceptor blockade. (1980) (57)
- Long-term BP monitoring in the evaluation of antihypertensive therapy. (1983) (55)
- Heredity and hypertension: impact on metabolic characteristics. (1992) (55)
- Monotherapy with labetalol compared with propranolol. Differential effects by race. (1985) (54)
- Hypertension: steps forward and steps backward. The Joint National Committee fifth report. (1993) (54)
- Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension. (1997) (54)
- Hypertension in the aged: a pathophysiologic basis for treatment. (1989) (52)
- The first report of the Systolic and Pulse Pressure (SYPP) Working Group. (1999) (51)
- Combination therapy with diuretics: an evolution of understanding. (1996) (50)
- Clinical safety and tolerability of losartan. (1997) (49)
- Incications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003 (2005) (49)
- Transdermal administration of clonidine for treatment of high BP. (1984) (46)
- Assessment of renin dependency of hypertension with a dipeptide renin inhibitor. (1990) (46)
- Effect of chelation treatment with dimercaptosuccinic acid (DMSA) on lead-related blood pressure changes. (1994) (45)
- Comparative accuracy of three automated techniques in the noninvasive estimation of central blood pressure in men. (1998) (45)
- Disparate Relationships Between Blood Pressure and Left Ventricular Mass in Patients With and Without Left Ventricular Hypertrophy (1987) (45)
- Impact of left ventricular hypertrophy on blood pressure responses to exercise. (1992) (44)
- Renin subgroups in essential hypertension. (1982) (44)
- Acute pharmacokinetic and hemodynamic effects of intravenous bolus dosing of nicardipine. (1990) (44)
- Diastolic blood pressure as a determinant of Doppler left ventricular filling indexes in normotensive adolescents. (1987) (43)
- Safety issues during antihypertensive treatment with angiotensin converting enzyme inhibitors. (1988) (42)
- A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II). (1976) (42)
- Low and High Renin Essential Hypertension: A Comparison of Clinical and Biochemical Characteristics (1981) (41)
- Virological investigations in sudden unexpected deaths in infancy (SUDI) (2010) (41)
- Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system. (1984) (40)
- Ambulatory blood pressure monitoring. Hypertensive Diseases Committee, American College of Cardiology. (1994) (40)
- Arterial properties of early hypertension. (1991) (40)
- Coronary heart disease and hypertension. (1994) (39)
- Echocardiographic evaluation of left ventricular hypertrophy. (1986) (39)
- Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril (2013) (39)
- The Abrupt Discontinuation of Antihypertensive Treatment (1979) (39)
- Whole-day blood pressure. (1988) (38)
- Reproducibility of the whole-day blood pressure pattern in essential hypertension. (1982) (38)
- Studies of the penetration of the blood brain barrier by atrial natriuretic factor. (1987) (38)
- Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation. (2001) (38)
- Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat. (1991) (37)
- Gender Differences in Vascular Compliance in Young, Healthy Subjects Assessed by Pulse Contour Analysis (2001) (37)
- The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol. (1978) (37)
- Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension (2006) (36)
- Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. (1994) (36)
- Renin reactivity as a determinant of responsiveness to antihypertensive treatment. (1977) (35)
- Coagulation and inhibitory and fibrinolytic proteins in essential hypertension. (1993) (35)
- The effect of antihypertensive drugs on vascular compliance (2001) (34)
- Beta-blockers and plasma renin activity in hypertension. (1974) (33)
- Echocardiographic left ventricular hypertrophy in hypertension. (1983) (33)
- Effects of beta adrenergic blocking agents on plasma renin activity in the conscious rabbit. (1974) (33)
- Whole-day BP monitoring in ambulatory normotensive men. (1985) (32)
- Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension (1986) (32)
- Cardiovascular and metabolic characteristics of hypertension. (1991) (31)
- Prospective parental consent for autopsy research following sudden unexpected childhood deaths: a successful model (2009) (31)
- Atrial natriuretic factor-induced vasodepression occurs through central nervous system. (1988) (31)
- Is high blood pressure a late manifestation of the hypertension syndrome? (1999) (30)
- Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension. (1997) (30)
- The Effects of Clonidine and Propranolol, Separately and in Combination, on Blood Pressure and Plasma Renin Activity in Essential Hypertension (1978) (29)
- Definition of normalcy in whole-day ambulatory blood pressure monitoring. (1985) (29)
- Severe hypertension induced by naloxone. (1985) (28)
- Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy. (1996) (28)
- Relationship of left ventricular structure to maximal heart rate during exercise. (1995) (28)
- Metabolic characteristics of hypertension: importance of positive family history. (1993) (27)
- Interactions of Mineralocorticoids and Pressor Agents in Vascular Smooth Muscle (1983) (27)
- Comparison of antihypertensive therapies by noninvasive techniques. (1989) (26)
- Assessing duration of antihypertensive effects with whole-day blood pressure monitoring. (1989) (26)
- Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition. (1992) (26)
- Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning. (1996) (26)
- Effects of a human-derived sodium transport inhibitor on in vitro vascular reactivity. (1989) (25)
- Histological examination in sudden unexpected death in infancy: evidence base for histological sampling (2011) (24)
- Effect of antihypertensive therapy on the circadian blood pressure pattern. (1987) (24)
- Diazoxide-induced renin release in diagnosis of remediable renovascular hypertension. (1976) (23)
- The Calcium Channel Blocker Nitrendipine in Single‐ and Multiple‐Agent Antihypertensive Regimens: Preliminary Report of a Multicenter Study (1984) (23)
- Comparative Antihypertensive Efficacy of Angiotensin Receptor Blocker‐Based Treatment in African‐American and White Patients (2005) (22)
- Comparison of bisoprolol with atenolol for systemic hypertension in four population groups (young, old, black and nonblack) using ambulatory blood pressure monitoring. Bisoprolol Investigators Group. (1993) (22)
- A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension. (1992) (21)
- Reproducibility of blood pressure values in normotensive subjects. (1985) (19)
- Vasoconstrictor effects of aldosterone in isolated vascular tissue. (1982) (19)
- Evaluating the diagnosis and prognosis of hypertension by automated blood pressure monitoring: outline of a symposium. (1988) (19)
- Enhancement of the pressor response to norepinephrine by angiotensin in the conscious rabbit. (1985) (17)
- Tandem mass spectrometry findings at autopsy for detection of metabolic disease in infant deaths: postmortem changes and confounding factors (2011) (17)
- Low‐dose diuretic and beta adrenoceptor blocker in essential hypertension (1980) (17)
- Central nervous system mediated vasodepressor action of atrial natriuretic factor. (1989) (17)
- A novel insulin mimetic without a proliferative effect on vascular smooth muscle cells. (2000) (17)
- Hypertension as a risk factor syndrome: therapeutic implications. (1993) (16)
- Phentolamine testing for alpha adrenergic participation in hypertensive patients: Independence from renin profiles (1977) (16)
- Effects of low-dose antihypertensive therapy in elderly patients with predominant systolic hypertension. (1983) (16)
- Effect of hemorrhage with and without fluid replacement on plasma renin activity. (1973) (16)
- The ethics of using placebo in hypertension clinical trials. (1999) (16)
- Blood Pressure Monitoring for Assessing the Duration of Action of Antihypertensive Treatment (1987) (16)
- Transdermal antihypertensive therapy: clinical and metabolic considerations. (1986) (16)
- Prevalence of carpal tunnel syndrome and wrist osteoarthritis in long-term paraplegic patients compared with controls (2014) (15)
- Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors. (1993) (15)
- Norepinephrine amplifies angiotensin II-induced vasoconstriction in rabbit femoral artery. (1992) (15)
- HYPERTENSION SURVEY IN A CENTRAL CITY FREE CHEST X‐RAY CLINIC (1973) (14)
- Automated blood pressure monitoring for the assessment of antihypertensive treatment. (1988) (14)
- Left ventricular hypertrophy and antihypertensive therapy. (1992) (14)
- Extended‐release felodipine in patients with mild to moderate hypertension (1994) (14)
- Effects of sustained-release nicardipine on regression of left ventricular hypertrophy in systemic hypertension. (1992) (13)
- Enhancement and prolongation of vascular smooth muscle contraction by aldosterone. (1983) (13)
- Place of Calcium Antagonists in Antihypertensive Therapy: Introduction and Round‐Table Discussion (1984) (13)
- Guidelines for assessing outcomes of antihypertensive treatment. (1999) (13)
- ULTRASTRUCTURAL FEATURES OF GAUCHER DISEASE TREATED WITH ENZYME REPLACEMENT THERAPY PRESENTING AS MESENTERIC MASS LESIONS (2006) (13)
- Comparisons of the effects of different long-acting delivery systems on the pharmacokinetics and pharmacodynamics of diltiazem. (1999) (13)
- Comparison between moexipril and atenolol in obese postmenopausal women with hypertension. (1996) (13)
- Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients. (1974) (13)
- Effects of sodium depletion on plasma renin activity and on the urinary excretion of cyclic AMP and aldosterone in hypoparathyroid patients. (1975) (13)
- Once-daily monotherapy with trandolapril in the treatment of hypertension. (1996) (13)
- Differential Effects of Diuresis and Beta‐Adrenoreceptor Blockade During Angiotensin‐Converting Enzyme Inhibition in Patients with Severe Hypertension (1982) (13)
- Strategies for improving blood pressure control. (1998) (12)
- Hypertension in Patients with Diabetes Mellitus: Treatment with a Centrally Acting Agent (1984) (12)
- A vasodilator that avoids renin stimulation and fluid retention: Antihypertensive treatment with trimazosin (1982) (12)
- Staphylococcal toxins in sudden unexpected death in infancy: experience from a single specialist centre (2011) (12)
- Hypertension with concomitant conditions: the changing role of beta-adrenoceptor blockade. (1991) (12)
- Combined diuretic and sympatholytic therapy in elderly patients with predominant systolic hypertension. (1983) (12)
- The measurement of arterial properties in hypertension. (2001) (12)
- Low Dose Oral and Transdermal Therapy of Hypertension (1985) (11)
- Controversies in the diagnosis and treatment of hypertension: a personal review of JNC V. (1993) (11)
- Combined Central and Peripheral Sympathetic Blockade: Absence of Additive Antihypertensive Effects (1983) (11)
- Effects on the renin-angiotensin system of agents acting at central and peripheral adrenergic receptors. (1983) (11)
- Centrally Acting Antihypertensive Agents: A Comparison of Lofexidine with Clonidine (1981) (11)
- Mild hypertension in the elderly. A comparison of prazosin and enalapril. (1989) (10)
- Antihypertensive Treatment: Considerations Beyond Blood Pressure Control (1989) (10)
- Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice. MIR and MITRA Study Groups. Myocardial Infarction Registry. Maximal Individual Therapy in Acute Myocardial Infarction . (2001) (10)
- Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertension. (1993) (10)
- Cardiovascular outcomes of treating high blood pressure. (1987) (10)
- Treatment of isolated systolic hypertension with labetalol in the elderly. (1990) (10)
- The adrenergic inhibitors. (1987) (10)
- Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertension. (1994) (10)
- Role of hypertension in coronary artery disease. (1996) (10)
- The effects of benazepril, a new angiotensin‐converting enzyme inhibitor, in mild to moderate essential hypertension: A multicenter study (1991) (9)
- Antihypertensive agents which inhibit sympathetic activity: potentially adverse effects of combination treatment. (1982) (9)
- Documentation of the effective length of action of antihypertensive treatment. (1990) (9)
- Controlling blood pressure throughout the day: issues in testing a new anti-hypertensive agent. (1995) (9)
- Sympathetic nervous system and hypertension. Therapeutic perspectives. (1989) (9)
- ISOLATED UNILATERAL TUBEROUS SCLEROSIS-ASSOCIATED RENAL CYSTIC DISEASE IN A NEONATE (2005) (9)
- Measurement of short-term, intermediate, and long-term outcomes of treating hypertension. (1996) (9)
- The effects of steroid hormones on vascular tissue. (1984) (9)
- Saturday, 25 August 2012 (2012) (9)
- The relationship of arterial compliance with endothelial-derived proteins of the hemostatic system. (1993) (9)
- Single-agent and combination therapy of essential hypertension. (1984) (9)
- Automated blood pressure monitoring: a new dimension in diagnosis. (1988) (8)
- Blood pressure rebound following withdrawal of antihypertensive treatment. (1978) (8)
- Hypertension in the elderly: 24 h ambulatory blood pressure results from a placebo-controlled trial. (1995) (8)
- Unsolved problems in treating hypertension: rationale for new approaches. (1998) (8)
- Endogenous opioid peptides: do they mediate the acute antihypertensive action of clonidine in humans? (1986) (8)
- Role of routine neuropathological examination for determining cause of death in sudden unexpected deaths in infancy (SUDI) (2011) (8)
- Fosinopril: A New Generation of Angiotensin-Converting Enzyme Inhibitors (1992) (8)
- The use of short-term ambulatory blood pressure monitoring in differing forms of hypertension. (1983) (8)
- Centrally Acting Antihypertensive Agents: A Brief Overview (1984) (8)
- Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction (2004) (8)
- Effects of angiotensin II on pressor responses to norepinephrine in humans. (1991) (8)
- Rationalizing the treatment of hypertension. (2001) (7)
- Antihypertensive dose-response relationships: studies with the selective alpha 1-blocking agent terazosin. (1991) (7)
- Diastolic blood pressure and left ventricular filling. (1988) (7)
- P-wave configuration as an indicator of echocardiographic indices of cardiac structure and function in normotensive adolescents. (1990) (7)
- Beta-adrenoreceptor blockade in the conscious rabbit: effects on plasma renin activity and blood pressure. (1975) (7)
- Saralasin testing for renin-dependent hypertension. (1979) (6)
- Assessment of left ventricular systolic and diastolic function with Doppler echocardiography in hypertensive patients receiving intravenous medroxalol. (1990) (6)
- Once-daily administration of acebutolol in treatment of hypertension. (1985) (6)
- Sustained-release nicardipine in mild-to-moderate hypertension. (1993) (6)
- D046: Antihypertensive dose response of Omapatrilat, a vasopeptidase inhibitor, in mild to moderate hypertension (1999) (6)
- beta-Adrenergic receptors and renin release: studies with beta-adrenoreceptor-blocking agents in the conscious rabbit. (1975) (6)
- Suppression of renin release by timolol. (1976) (6)
- Angiotensin receptor blockers and the cardiovascular continuum: what future is indicated by recent successes? (2003) (5)
- Applications of ambulatory blood pressure monitoring in clinical practice. (1991) (5)
- Translating data on antihypertensive drugs into clinical practice. (1998) (5)
- C008: Opera: Design and rationale for a novel placebo control trial testing the benefits of blood pressure reduction in patients with stage I isolated systolic hypertension (2000) (5)
- Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme. (1982) (5)
- Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial (2006) (5)
- The sympathetic nervous system in primary hypertension. (1982) (4)
- THE VALSARTAN ANTIHYPERTENSIVE LONGTERM USE EVALUATION (VALUE) TRIAL: FINAL PATIENTS DEMOGRAPHICS (2000) (4)
- Pressure, platelets, and plaque: the central role of angiotensin II in cardiovascular pathology. Concluding comment. (2001) (4)
- The Role of Renin in the Antihypertensive Action of β-Adrenoreceptor Blocking Agents (2012) (4)
- Senges Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction ( ANTIBIO ) trial (2004) (4)
- [Predictive value of an ischemia test in men and women with stable angina pectoris in clinical practice. Results of the heart catheter registry of the Working Society of Senior Hospital Cardiologists]. (2006) (4)
- Comparisons in a competitive world: when is one drug superior to another? (2000) (4)
- A physiological basis for the treatment of essential hypertension. (1978) (4)
- Exercise and elderly persons. (2001) (4)
- Ticrynafen-induced acute renal failure. (1981) (4)
- Central and peripheral blockade of the sympathetic nervous system. (1984) (4)
- [PTCA Register of ALKK (Professional Organization of Leading Cardiology Hospital Physicians): report 1998 and 1999]. (2000) (4)
- Ambulatory blood pressure measurements: practical considerations, methodology, feasibility, and implications in the management of hypertension. (1988) (3)
- Pharmacological stimulation of renin secretion within the kidney. (1977) (3)
- Angiotensin blockade in studies of the feedback control of renin release in rats and rabbits. (1975) (3)
- What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring? (1999) (3)
- The challenge of very mild hypertension: should treatment be sooner or later? (1998) (3)
- The evolution of antihypertensive therapy: current theoretical conditions and individualized treatment options. (1992) (3)
- Adverse effects of sudden withdrawal of antihypertensive medication. (1980) (3)
- Antihypertensive treatment with a dual-acting beta-blocker in the elderly. (1993) (3)
- Using placebo in hypertension clinical trials: new information and new opportunities (2008) (3)
- Blood pressure in normal subjects (1990) (3)
- Biochemical cardiac risk factors during diuretic therapy. (1982) (3)
- Disparate responses of blood pressure to adrenergic stimuli during beta blockade. (1985) (3)
- Ambulatory blood pressure monitoring: clinical uses. (1992) (3)
- Correlates of cardiac structure and function in normotensive adolescents. (1988) (2)
- Epidemiology and prevention. (1997) (2)
- Management of hypertensive patients with special problems. (1989) (2)
- The hypertension syndrome and the sympathetic nervous system (1992) (2)
- Comparative antihypertensive and endocrinologic effects of clonidine and prazosin in patients with essential hypertension. (1984) (2)
- TREATMENT OF HYPERTENSION WITH AN ANTIHYPERTENSIVE AGENT POSSESSING VASODILATOR ACTIVITY (1975) (2)
- Angiotensin II induced amplification of the vasoconstrictor response to norepinephrine and clonidine. (1987) (2)
- Evaluating risks and events in hypertension: an overview of the hypertension syndrome. (1997) (2)
- , 3-Blockers and Plasma Renin Activity in Hypertension (2006) (1)
- EFFECT OF DIFFERENTLY INDUCED NOREPINEPHRINE INCREMENTS ON NOREPINEPHRINE SULFATE IN PLASMA 1145 (1997) (1)
- The Effects of Nebivolol-Valsartan Single-Pill Combinations in Reducing Blood Pressure in Patients with Stage I or II Hypertension. (2016) (1)
- Medical and non-medical approaches to renovascular hypertension. (1997) (1)
- Severe hypertension: special problems in the elderly. (1983) (1)
- Effects of Beta-Adrenergic Antagonists and Diuretics on Kidney Function in Hypertensive Patients (1984) (1)
- Effects of a human urine derived sodium-potassium pump inhibitor on isolated rabbit femoral artery and atria. (1988) (1)
- When hypertension and diabetes coexist: strategies for cardiorenal protection. (2010) (1)
- Effects of di-isopropylfluorophosphate and isopropanol on the measurement of plasma renin activity. (1980) (1)
- Antihypertensive therapy during pregnancy. (1983) (1)
- The sympathetic nervous system and hypertension: Mechanisms and treatment (1993) (1)
- Prolonged calcium channel blocker therapy of hypertension. (1988) (1)
- Characterization of a Low Molecular Weight Na‐K-ATPase Inhibitor of Urinary Origin (1994) (1)
- The changing focus of hypertension. (1995) (1)
- Clinical Trials of Antihypertensive Agents (1990) (1)
- Automatic blood pressure recorders and 24 hour monitoring (1987) (1)
- [Therapy of pregnancy hypertension]. (1986) (0)
- Twenty-four hour blood pressure control : Clinical importance, measurement, and antihypertensive efficacy (1997) (0)
- [30-day mortality after heart surgery: a pilot project of the Working Party of Directors of Hospital Cardiology Departments]. (2008) (0)
- THE USE OF CALCIUM ANTAGONISTS IN HYPERTENSIVE PATIENTS WITH CONCOMITANT DISEASE : FOCUS ON NICARDIPINE, NICE, FRANCE, SEPTEMBER 13, 1989 (1990) (0)
- Roundtable discussion on the use of transdermal medication: clinical characteristics and skin reactions (1984) (0)
- Consistency of the 24 hour blood pressure profile (1982) (0)
- Panel-Discussion: the role of clonidine in the treatment of mild hypertension (1984) (0)
- A role of eNOS dimer stability in essential hypertension (2013) (0)
- Endothelial dysfunction : Linking hypertension to systemic and local disease (1998) (0)
- Nonpharmacological treatment of hypertension (1993) (0)
- [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)]. (1988) (0)
- Treatment of systolic hypertension. (1983) (0)
- Twin born with a skeletonized hand in twin-to-twin transfusion syndrome treated with laser ablation in pregnancy (2016) (0)
- Clinical trials in hypertension: an uncertain impact on physician practice. (2000) (0)
- Hypertension: meeting therapeutic challenges, providing effective management. (1991) (0)
- The role of aldosterone in the response to treatment of primary hypertension. (1982) (0)
- Angiotensin II receptor antagonists: new paradigms in the treatment of hypertension. Introduction. (2001) (0)
- Use of centrally-acting agonists in the treatment of mild hypertension in the elderly patient (1984) (0)
- Clinical implications of angiotensin II blockade (1996) (0)
- An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension (1987) (0)
- Clinical trials report. When can treatment of hypertension be stopped? (2001) (0)
- Treatment of Hypertension in the Elderly (1986) (0)
- The evolving paradigm of hypertension. (1995) (0)
- The degree of atrial natriuretic peptide (ANP)-induced contraction inhibition is dependent on spare receptors. (1989) (0)
- Forging a partnership to control hypertension (1995) (0)
- A046: Well-controlled hypertension in obese patients remains well-controlled during weight reduction on sibutramine treatment (2000) (0)
- Dose-response of the combination of irbesartan and hydrochlorothiazide in hypertensive patients. (1999) (0)
- Noninvasive diagnostic procedures in the evaluation and treatment of hypertensive patients. (1983) (0)
- Defining outcomes of hypertension treatment (1996) (0)
- Immediate treatment of severe hypertension. Widening the options. (1989) (0)
- Erratum to "Second Consensus on Treatment of Patients Recently Diagnosed with Mild Hypertension and Low Cardiovascular Risk". [YMCD 45/10 (October 2020) 100653]. (2021) (0)
- Measuring the whole day blood pressure implications for pharmacologic studies (1984) (0)
- Clinical benefits of combination therapy in managing hypertension: a paradigm for managed care. (1999) (0)
- Advances in Hypertension (1996) (0)
- Clinical cardiovascular effects of sibutramine : Symposium : Cardiovascular considerations in obesity and its management (1999) (0)
- [Certification in cardiology : Contra: The concept should be improved]. (2018) (0)
- [Mild therapeutic hypothermia: Improved survival after resuscitation]. (2015) (0)
- [Effect of glucagon on changes of carbohydrate metabolism in experimental hemorrhagic shock]. (1975) (0)
- D21 A comparison of the once-daily administration of 50 mg extended release and 100 mg immediate release metoprolol tablets in patients with mild to moderate hypertension (1997) (0)
- VASCULAR OVERLOAD CONCEPT. AUTHORS' REPLY (1995) (0)
- Clinical experience with converting-enzyme inhibitors in hypertension. (1987) (0)
- Acute reversible renal impairment produced by a uricosuric diuretic. (1980) (0)
This paper list is powered by the following services:
